本文選題：卒中后認(rèn)知功能障礙 + 基質(zhì)金屬蛋白酶9��； 參考：《鄭州大學(xué)》2017年博士論文

【摘要】：背景:卒中后認(rèn)知功能障礙(Post-stroke cognitive impairment,PSCI)是腦卒中(缺血性或出血性)后繼發(fā)的認(rèn)知功能減退,臨床治療效果差,嚴(yán)重影響腦卒中患者的預(yù)后和生活質(zhì)量,對(duì)該病的早期發(fā)現(xiàn)和干預(yù)是治療關(guān)鍵,但由于PSCI起病隱匿,早期不易被察覺和診斷,因此急需一種有效的生物學(xué)指標(biāo)來輔助早期診斷�；|(zhì)金屬蛋白酶9(Matrix metallprotenaine 9,MMP9)生理狀態(tài)下參與調(diào)控海馬突觸可塑性和學(xué)習(xí)記憶過程,病理狀態(tài)下參與細(xì)胞外基質(zhì)破壞、炎癥浸潤和血腦屏障破壞,在動(dòng)脈粥樣硬化、缺血性腦損傷及血管性癡呆中表達(dá)增高,因此,PSCI中MMP9表達(dá)水平及與認(rèn)知功能減退可能存在一定關(guān)系;另外,MMP9/C1562T(rs3918242)基因多態(tài)性與動(dòng)脈粥樣硬化、缺血性腦梗死的發(fā)生有關(guān),有必要進(jìn)一步探討MMP9/C1562T(rs3918242)基因多態(tài)性與PSCI發(fā)生的關(guān)系,為早期干預(yù)提供依據(jù)。目的:1.篩查PSCI在腦梗死急性期和恢復(fù)期發(fā)生情況及可能的危險(xiǎn)因素,2.明確MMP9/C1562T(rs3918242)基因多態(tài)性與腦梗死及PSCI的發(fā)病關(guān)系,3.確定血清MMP9水平對(duì)缺血性腦卒中患者認(rèn)知功能的影響以及不同部位梗死認(rèn)知域受損的差異。方法:1.連續(xù)登記2013年5月至2016年9月在新鄉(xiāng)醫(yī)學(xué)院第一附屬醫(yī)院神經(jīng)內(nèi)科就診的缺血性腦卒中患者,收集臨床資料及各種腦血管疾病危險(xiǎn)因素,所有患者均完成相關(guān)檢查,所有納入患者均同意登記臨床資料、認(rèn)知功能評(píng)估、抽血及定期隨訪。2.按照卒中后認(rèn)知功能障礙篩查流程分別在發(fā)病2周和3月兩個(gè)時(shí)間節(jié)點(diǎn)進(jìn)行認(rèn)知功能篩查,對(duì)缺血性腦卒中繼發(fā)認(rèn)知功能障礙的患者進(jìn)行詳細(xì)認(rèn)知功能評(píng)估,并抽血備檢。3.采用PCR-限制性內(nèi)切酶技術(shù)及瓊脂糖凝膠電泳技術(shù)對(duì)最終入組患者進(jìn)行MMP9/C1562T(rs3918242)基因多態(tài)性分型,統(tǒng)計(jì)各基因型頻率;采用酶聯(lián)免疫吸附試驗(yàn)檢測樣本中MMP9濃度。結(jié)果:1.PSCI在卒中后2周發(fā)病率為7.9%(61/769),卒中后3月發(fā)病率25.59%(151/590),總發(fā)病率27.57%(212/769)2.PSCI組與認(rèn)知正常腦梗死組在神經(jīng)功能缺損程度比較顯示,兩組之間NIHSS評(píng)分無顯著性差異(P0.05);按照TOAST分型各類型構(gòu)成比兩組之間比較無顯著性差異(P0.05)。3.腦血管疾病危險(xiǎn)因素多因素分析顯示,高同型半胱氨酸血癥分別增加了腦梗死(P0.01)和PSCI(P0.01)的發(fā)病風(fēng)險(xiǎn);OSAS增加了腦梗死的發(fā)病風(fēng)險(xiǎn)(P0.01),但是對(duì)于PSCI的發(fā)病風(fēng)險(xiǎn)無統(tǒng)計(jì)學(xué)意義(P0.05);糖尿病雖增加了腦梗死以及PSCI的風(fēng)險(xiǎn),但均不具有統(tǒng)計(jì)學(xué)意義(P0.05)。4.MMP9/C1562T(rs3918242)基因位點(diǎn)突變對(duì)腦梗死的發(fā)生具有統(tǒng)計(jì)學(xué)意義(χ2=10.35,P0.01)。其中CC基因型對(duì)腦梗死發(fā)病的風(fēng)險(xiǎn)具有統(tǒng)計(jì)學(xué)意義(OR=4.06,95%CI:1.49-11.11,P0.01),提示CC基因型是腦梗死發(fā)生的危險(xiǎn)因素。而且C等位基因頻率分布差異與腦梗死的發(fā)生具有統(tǒng)計(jì)學(xué)意義(OR=0.59,95%CI:0.42-0.82,P0.01)。但MMP9/C1562T(rs3918242)基因位點(diǎn)突變對(duì)PSCI的發(fā)生不具有統(tǒng)計(jì)學(xué)意義(χ2=4.43,P0.05)5.三組受試者血清MMP9濃度比較顯示,差別具有統(tǒng)計(jì)學(xué)意義(P0.05)。組間比較顯示PSCI組明顯高于腦梗死組(P0.05)和正常對(duì)照組(P0.01),差別具有統(tǒng)計(jì)學(xué)意義;認(rèn)知正常腦梗死患者血清MMP9濃度也明顯高于正常對(duì)照組,差別具有統(tǒng)計(jì)學(xué)意義(P0.01)。6.認(rèn)知功能缺損程度危險(xiǎn)因素分析:三組受試Mo CA分值與糖尿病、高同型半胱氨酸血癥及MMP9進(jìn)行偏相關(guān)性分析顯示,Mo CA分值與空腹血糖值(P0.05)、血同型半胱氨酸水平(P0.01)顯著負(fù)相關(guān),具有統(tǒng)計(jì)學(xué)意義(P0.01)。而且血清MMP9水平與空腹血糖值(P0.05)、血同型半胱氨酸水平(P0.01)、NIHSS評(píng)分(P0.01)呈正相關(guān),具有統(tǒng)計(jì)學(xué)意義。血清MMP9水平、NIHSS評(píng)分與Mo CA分值均不相關(guān)(P0.05)。7.PSCI患者在視空間能力(P0.01)、執(zhí)行功能(P0.01)及計(jì)算力(P0.05)3個(gè)認(rèn)知領(lǐng)域受損嚴(yán)重,而在學(xué)習(xí)記憶、注意力、語言功能和定向力幾個(gè)認(rèn)知域受損不明顯(P0.05)。8.PSCI組患者額葉(P0.01)及基底節(jié)區(qū)(P0.01)部位梗死所占比例明顯升高,差異具有統(tǒng)計(jì)學(xué)意義。而在枕葉(P0.05)及腦干(P0.05)部位梗死所占比例明顯減少,差異具有統(tǒng)計(jì)學(xué)意義。額葉梗死患者在視空間能力(P0.05)、語言功能(P0.05)、執(zhí)行功能(P0.05)下降明顯,而基底節(jié)區(qū)梗死在學(xué)習(xí)記憶(P0.05)和計(jì)算力(P0.05)方面下降明顯。結(jié)論:1.MMP9/C1562T(rs3918242)基因多態(tài)性與腦梗死的發(fā)病密切相關(guān),C等位基因是腦梗死發(fā)病的危險(xiǎn)因素;MMP9/C1562T(rs3918242)基因多態(tài)性與腦梗死后是否出現(xiàn)認(rèn)知功能障礙關(guān)系不明顯。2.血清MMP9水平在PSCI中明顯升高,血清同型半胱氨酸水平可作為評(píng)估PSCI認(rèn)知功能損害程度的間接指標(biāo)。3.額葉和基底節(jié)區(qū)腦梗死更容易出現(xiàn)認(rèn)知功能障礙,額葉梗死患者在視空間能力、語言功能、執(zhí)行功能下降明顯,而基底節(jié)區(qū)梗死的患者在學(xué)習(xí)記憶和計(jì)算力方面下降明顯。背景:海馬神經(jīng)元突觸后膜NMDA受體被激活后可調(diào)控突觸后膜鈣離子通道,介導(dǎo)鈣離子內(nèi)流,參與了學(xué)習(xí)記憶的形成和突觸功能可塑性。有研究證實(shí),MMP9可通過激活海馬CA1區(qū)NMDA受體,提高CA3-CA1神經(jīng)傳導(dǎo)通路長時(shí)程增強(qiáng)(Long-term potentiation,LTP),改善神經(jīng)突觸可塑性,促進(jìn)學(xué)習(xí)記憶。但是在血管性癡呆或血管性認(rèn)知功能障礙小鼠模型中,發(fā)現(xiàn)海馬CA1區(qū)MMP9表達(dá)增高,因此,MMP9/NMDA受體通路在低灌注腦損傷后認(rèn)知功能障礙中的作用需要深入探討。目的:探討MMP9/NMDA受體通路在血管性認(rèn)知功能障礙中對(duì)LTP的作用及機(jī)制。方法:1.采用雙側(cè)頸動(dòng)脈結(jié)扎方法制作慢性大腦低灌注模型,采用水迷宮自動(dòng)記錄儀評(píng)估模型鼠學(xué)習(xí)記憶能力。2.應(yīng)用場電位記錄系統(tǒng)分析記錄海馬離體腦片CA3/CA1通路LTP變化。3.通過調(diào)控MMP9濃度及NMDA受體活性研究MMP9/NMDA受體通路對(duì)LTP的作用和機(jī)制。結(jié)果:1.慢性大腦低灌注小鼠海馬LTP受損(P0.01),學(xué)習(xí)記憶能力下降(P0.01)。2.外源性MMP9提高了正常小鼠海馬CA1區(qū)LTP(P0.01),在慢性大腦低灌注腦損傷中,MMP9可加重VCI后LTP的損害(P0.01),應(yīng)用MMP9抑制劑或NMDA受體拮抗劑分別作用于VCI小鼠海馬腦片,可使受損的LTP提高(P0.01)。3.同時(shí)應(yīng)用MMP9抑制劑和NMDA受體拮抗劑作用于VCI小鼠海馬腦片使LTP提高程度大于二者分別應(yīng)用之和(P0.05)。結(jié)論:生理狀態(tài)下MMP9激活NMDA受體,有助于增強(qiáng)LTP,改善突觸可塑性,提高學(xué)習(xí)記憶;慢性大腦低灌注后引起的VCI小鼠中MMP9過度激活了NMDA受體,使海馬CA3-CA1區(qū)LTP減弱,損害突觸可塑性,導(dǎo)致學(xué)習(xí)記憶受損。
[Abstract]:Background: Post-stroke cognitive impairment (PSCI) is a secondary cognitive impairment after stroke (ischemic or hemorrhagic). The effect of clinical treatment is poor, which seriously affects the prognosis and quality of life of stroke patients. Early detection and intervention of this disease is the key to treatment, but because of PSCI onset, the early stage is not. It is easy to be detected and diagnosed, so an effective biological indicator is urgently needed to assist early diagnosis. The physiological state of matrix metalloproteinase 9 (Matrix metallprotenaine 9, MMP9) is involved in the regulation of hippocampal synaptic plasticity and learning and memory process, in pathological condition, involvement of extracellular matrix damage, inflammatory infiltration and blood brain barrier damage, in porridge There is a certain relationship between the expression level of MMP9 in PSCI and the impairment of cognitive function. In addition, the polymorphism of MMP9/C1562T (rs3918242) gene is related to atherosclerosis and ischemic cerebral infarction. It is necessary to further explore the polymorphism of MMP9/C1562T (rs3918242) gene. The relationship between sex and PSCI in order to provide evidence for early intervention. Objective: 1. screening of PSCI in acute and Convalescent Cerebral Infarction and possible risk factors. 2. the relationship between MMP9/C1562T (rs3918242) gene polymorphism and cerebral infarction and PSCI, and 3. to determine the effect of serum MMP9 level on cognitive function of ischemic stroke patients Methods: 1. patients with ischemic stroke in the Department of Neurology, First Affiliated Hospital of Xinxiang Medical College, were registered from May 2013 to September 2016. Clinical data and risk factors of various cerebrovascular diseases were collected and all patients were completed. All the patients agreed to register. Bed data, cognitive function assessment, blood extraction, and regular follow-up.2. were screened for cognitive function at two time nodes of 2 weeks and March respectively according to the post-stroke cognitive dysfunction screening process, and a detailed cognitive function assessment was performed for patients with secondary cognitive dysfunction secondary to ischemic stroke, and PCR- restrictive endonuclease was used for.3.. Techniques and agarose gel electrophoresis were used for the MMP9/C1562T (rs3918242) polymorphism of the final group, and the frequency of each genotype was counted. The MMP9 concentration in the sample was detected by ELISA. Results: the incidence of 1.PSCI was 7.9% (61/769) at 2 weeks after stroke and 25.59% (151/590) after stroke in March, and the total incidence rate was 27.57%. 212/769) in the group 2.PSCI and the cognitive normal cerebral infarction group, there was no significant difference in the degree of neural function defect between the two groups (P0.05), and there was no significant difference between the types of TOAST types and the two groups (P0.05), the multiple factor analysis of the risk factors of.3. cerebrovascular disease showed that hyperhomocysteinemia increased respectively. The risk of cerebral infarction (P0.01) and PSCI (P0.01) was added; OSAS increased the risk of cerebral infarction (P0.01), but there was no statistical significance for the risk of PSCI (P0.05); diabetes increased the risk of cerebral infarction and PSCI, but did not have statistical meaning (P0.05).4.MMP9/C1562T (rs3918242) mutation to cerebral infarction. There were statistical significance (x 2=10.35, P0.01). Among them, the CC genotype was statistically significant (OR=4.06,95%CI:1.49-11.11, P0.01), suggesting that the CC genotype was a risk factor for cerebral infarction, and the difference in the frequency distribution of C alleles was statistically significant (OR=0.59,95%CI:0.42-0.82, P). 0.01). But the mutation of MMP9/C1562T (rs3918242) gene loci did not have statistical significance to the occurrence of PSCI (x 2=4.43, P0.05) 5. three groups, the serum MMP9 concentration comparison showed that the difference was statistically significant (P0.05). The comparison between groups showed that PSCI group was significantly higher than the cerebral infarction group (P0.05) and normal control group (P0.01), the difference was statistically significant. The serum MMP9 concentration in the patients with normal cerebral infarction was also significantly higher than that in the normal control group, and the difference was statistically significant (P0.01).6. cognitive impairment risk factors analysis: three groups of subjects Mo CA score and diabetes, hyperhomocysteinemia and MMP9 partial correlation analysis showed that the Mo CA score and fasting blood glucose (P0.05), blood same type The significant negative correlation of cysteine level (P0.01) was statistically significant (P0.01). The serum MMP9 level was positively correlated with the fasting blood glucose (P0.05), blood homocysteine level (P0.01) and NIHSS score (P0.01). The serum MMP9 level was not related to the Mo CA score (P0.05) in the visual space ability ( P0.01), 3 cognitive domains of executive function (P0.01) and computing power (P0.05) were severely damaged, while in the cognitive domains of learning, memory, attention, language function and orientation (P0.05), the proportion of the frontal lobe (P0.01) and the basal ganglia (P0.01) site of the.8.PSCI group was significantly increased, and the difference was statistically significant. In the occipital lobe (P0.05), the difference was statistically significant. The proportion of infarcts in the brain stem (P0.05) site was significantly reduced, and the difference was statistically significant. The patients with frontal lobe infarction were significantly decreased in visual space ability (P0.05), language function (P0.05) and executive function (P0.05), while basal ganglia infarction decreased in learning memory (P0.05) and calculation force (P0.05). Conclusion: 1.MMP9/C1562T (rs3918242) gene is more than that of P0.05 (rs3918242) gene. State sex is closely related to the onset of cerebral infarction. C allele is a risk factor for cerebral infarction. The relationship between MMP9/C1562T (rs3918242) gene polymorphism and cognitive impairment after cerebral infarction is not obvious. The level of.2. serum MMP9 is significantly increased in PSCI. Serum homocysteine level can be used to evaluate the degree of impairment of PSCI cognitive function. Cognitive impairment is more likely to occur in the frontal lobe and the basal ganglia infarction. The patients with frontal lobe infarction have a significant decline in visual spatial ability, language function, and executive function, while the patients with basal ganglia infarction decrease in learning and memory and computational power. Background: the NMDA receptor in the hippocampal neurons of the hippocampal neurons can be regulated after the activation of the postsynaptic membrane. The postsynaptic membrane calcium channel, which mediates calcium ion influx, participates in the formation of learning and memory and the plasticity of synaptic function. Some studies have shown that MMP9 can enhance the long term enhancement (Long-term potentiation, LTP) of the CA3-CA1 nerve conduction pathway by activating the NMDA receptor in the hippocampus CA1 region, improving the plasticity of synapse and promoting learning and memory. In the mice model of vascular dementia or vascular cognitive impairment, the expression of MMP9 in the CA1 region of the hippocampus is increased. Therefore, the role of MMP9/NMDA receptor pathway in cognitive dysfunction after low perfusion brain injury needs to be explored. Objective: To explore the role and mechanism of MMP9/NMDA receptor pathway to LTP in vascular cognitive impairment. Methods: 1. The model of chronic cerebral hypoperfusion was made with bilateral carotid artery ligation. The learning and memory ability of model rats was evaluated by water maze automatic recorder (.2.). The field potential recording system was used to record the LTP change of CA3/CA1 pathway in the brain slices of the hippocampus. The effect of MMP9/NMDA receptor pathway on LTP by regulating the concentration of MMP9 and the activity of NMDA receptor was studied and the effect of MMP9/NMDA receptor pathway on LTP was studied. Results: 1. the hippocampal LTP damage in chronic cerebral hypoperfusion mice (P0.01), learning and memory ability decreased (P0.01).2. exogenous MMP9 increased the CA1 region LTP (P0.01) in normal mice hippocampus. In chronic cerebral hypoperfusion brain injury, MMP9 could aggravate VCI LTP damage after VCI (P0.01). Hippocampal slices can make the damaged LTP increase (P0.01).3. and use MMP9 inhibitors and NMDA receptor antagonists to act on VCI mouse hippocampal slices to make LTP increase more than two, respectively, and (P0.05). Conclusion: MMP9 activation NMDA receptor in physiological state helps to enhance LTP, improve synaptic plasticity, improve learning and memory; chronic brain low After reperfusion, MMP9 overactivates NMDA receptor in VCI mice, resulting in the weakening of LTP in CA3-CA1 area and damage of synaptic plasticity, resulting in impaired learning and memory.

【學(xué)位授予單位】：鄭州大學(xué)
【學(xué)位級(jí)別】：博士
【學(xué)位授予年份】：2017
【分類號(hào)】：R749.13

【相似文獻(xiàn)】

相關(guān)期刊論文 前1條

1 高健;李淑萍;;認(rèn)知功能訓(xùn)練聯(lián)合藥物治療對(duì)急性腦梗死患者認(rèn)知功能的影響[J];臨床醫(yī)學(xué);2014年05期

相關(guān)博士學(xué)位論文 前2條

1 趙建華;基質(zhì)金屬蛋白酶9在血管性認(rèn)知功能障礙中的作用和機(jī)制[D];鄭州大學(xué);2017年

2 成戎川;側(cè)腦室后角旁白質(zhì)損害所致認(rèn)知功能障礙特征和功能磁共振研究[D];第三軍醫(yī)大學(xué);2016年

，

本文編號(hào)：1781259